Combined Analysis by Peak and Submaximal Exercise Parameters Delineates Underlying Mechanisms of Poor Exercise Performance in Fontan Patients

• by Takeshi Tsuda, Daphney Kernizan, Md Jobayer Hossain

• June 18, 2026

Investigational Drug Shows Potentialin Phase 3 Obesity Trial

In a 76-week randomized trial, patients with obesity without diabetes who received survodutide achieved greater weight loss and favorable changes in several metabolic measures compared with those who received placebo.

• by Andrea Surnit

• June 10, 2026

• 4 min

“Double-hit” precipitates fulminant cardiac dysfunction in a child with homozygous CAP2 variant: a case report

• by Zhenhui Pan, Jiaojiao Wan, Kaiyu Zhou, Min Tan, Yifei Li

• June 9, 2026

Side Effects: They Googled It

Patients are mining Reddit and TikTok for symptom intel while you're not — and a small study calls it epistemic injustice. Different knowledge, mutually unrecognized. Maybe ask where they've been reading before you wave it off as anecdote.

• by Kerri Miller

• May 27, 2026

• 6 min